ARTICLE
|
doi:10.20944/preprints202201.0164.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer,; neoadjuvant chemotherapy; elederly; HER2- positive; pathological complete response; safety
Online: 12 January 2022 (13:31:16 CET)